Bengaluru: Bharat Biotech group company Biovet, an innovative animal health vaccine producer based in Mallur, Karnataka, has ...

Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...

Ratner, who heads the pediatric infectious disease unit at NYU Langone’s Hassenfeld Children’s Hospital, tracks the history ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...

Experts are concerned about the Clade 1 mpox virus that has been spreading quickly in west and central Africa since 2023.

VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Advancement to Stage 2 of Infant Study Supported by Review of Stage 1 Safety and Tolerability Data ---- Company Expects to Announce VAX-31 ...